A randomized phase II study of degarelix combined with anti-androgen for prostate cancer

Trial Profile

A randomized phase II study of degarelix combined with anti-androgen for prostate cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Jan 2016

At a glance

  • Drugs Bicalutamide (Primary) ; Degarelix (Primary)
  • Indications Adenocarcinoma; Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Jun 2015 Interim results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
    • 13 May 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 20 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top